MÖLNDAL, Sweden, Sept. 4, 2025 /PRNewswire/ -- Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), the provider of…
~ Clinically Significant Patient Outcomes Demonstrate Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety…
NPM-139 has potential to provide Wegovy®-level efficacy with once or twice-yearly administration First-in-human Phase 1 study is expected to initiate…
Flexible carbon nanotube-based electrodes achieve high conductivity in brain connections with minimum tissue damage SEOUL, South Korea, Sept. 3, 2025…
WESTFORD, Mass., Sept. 3, 2025 /PRNewswire/ -- The global surgical robots market is rapidly changing, as advanced technologies converge with…
Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded…
ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis…
WOODLAND HILLS, Calif., Aug. 28, 2025 /PRNewswire/ -- Dr. Robert G. Hale, a leading oral and maxillofacial surgeon, announced the…
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M. Murthi Appointed Chief…
STAFFORD, Va., Aug. 26, 2025 /PRNewswire/ -- Greater Washington Oral and Maxillofacial Surgery is pleased to announce the opening of…